BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 26703468)

  • 1. SOCS2 Balances Metabolic and Restorative Requirements during Liver Regeneration.
    Masuzaki R; Zhao S; Valerius MT; Tsugawa D; Oya Y; Ray KC; Karp SJ
    J Biol Chem; 2016 Feb; 291(7):3346-58. PubMed ID: 26703468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The somatotropic axis during the physiological estrus cycle in dairy heifers--Effect on hepatic expression of GHR and SOCS2.
    Mense K; Meyerholz M; Gil Araujo M; Lietzau M; Knaack H; Wrenzycki C; Hoedemaker M; Piechotta M
    J Dairy Sci; 2015 Apr; 98(4):2409-18. PubMed ID: 25704974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The SOCS2 ubiquitin ligase complex regulates growth hormone receptor levels.
    Vesterlund M; Zadjali F; Persson T; Nielsen ML; Kessler BM; Norstedt G; Flores-Morales A
    PLoS One; 2011; 6(9):e25358. PubMed ID: 21980433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOCS2 is the critical regulator of GH action in murine growth plate chondrogenesis.
    Pass C; MacRae VE; Huesa C; Faisal Ahmed S; Farquharson C
    J Bone Miner Res; 2012 May; 27(5):1055-66. PubMed ID: 22228213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of leptin by metabolic state and its regulatory interactions with pituitary growth hormone and hepatic growth hormone receptors and insulin like growth factors in the tilapia (Oreochromis mossambicus).
    Douros JD; Baltzegar DA; Mankiewicz J; Taylor J; Yamaguchi Y; Lerner DT; Seale AP; Grau EG; Breves JP; Borski RJ
    Gen Comp Endocrinol; 2017 Jan; 240():227-237. PubMed ID: 27449341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SOCS2 negatively regulates growth hormone action in vitro and in vivo.
    Greenhalgh CJ; Rico-Bautista E; Lorentzon M; Thaus AL; Morgan PO; Willson TA; Zervoudakis P; Metcalf D; Street I; Nicola NA; Nash AD; Fabri LJ; Norstedt G; Ohlsson C; Flores-Morales A; Alexander WS; Hilton DJ
    J Clin Invest; 2005 Feb; 115(2):397-406. PubMed ID: 15690087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue-specific regulation of growth hormone (GH) receptor and insulin-like growth factor-I gene expression in the pituitary and liver of GH-deficient (lit/lit) mice and transgenic mice that overexpress bovine GH (bGH) or a bGH antagonist.
    Iida K; Del Rincon JP; Kim DS; Itoh E; Nass R; Coschigano KT; Kopchick JJ; Thorner MO
    Endocrinology; 2004 Apr; 145(4):1564-70. PubMed ID: 14726438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressor of cytokine signaling-2 limits intestinal growth and enterotrophic actions of IGF-I in vivo.
    Michaylira CZ; Simmons JG; Ramocki NM; Scull BP; McNaughton KK; Fuller CR; Lund PK
    Am J Physiol Gastrointest Liver Physiol; 2006 Sep; 291(3):G472-81. PubMed ID: 16574995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased linear bone growth by GH in the absence of SOCS2 is independent of IGF-1.
    Dobie R; Ahmed SF; Staines KA; Pass C; Jasim S; MacRae VE; Farquharson C
    J Cell Physiol; 2015 Nov; 230(11):2796-806. PubMed ID: 25833299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressor of cytokine signaling-2 deficiency induces molecular and metabolic changes that partially overlap with growth hormone-dependent effects.
    Rico-Bautista E; Greenhalgh CJ; Tollet-Egnell P; Hilton DJ; Alexander WS; Norstedt G; Flores-Morales A
    Mol Endocrinol; 2005 Mar; 19(3):781-93. PubMed ID: 15563548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SOCS2 mediates the cross talk between androgen and growth hormone signaling in prostate cancer.
    Iglesias-Gato D; Chuan YC; Wikström P; Augsten S; Jiang N; Niu Y; Seipel A; Danneman D; Vermeij M; Fernandez-Perez L; Jenster G; Egevad L; Norstedt G; Flores-Morales A
    Carcinogenesis; 2014 Jan; 35(1):24-33. PubMed ID: 24031028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro effects of somatostatin on the growth hormone-insulin-like growth factor axis in orange-spotted grouper (Epinephelus coioides).
    Wang B; Jia J; Yang G; Qin J; Zhang C; Zhang Q; Sun C; Li W
    Gen Comp Endocrinol; 2016 Oct; 237():1-9. PubMed ID: 26526981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haplotype insufficiency for suppressor of cytokine signaling-2 enhances intestinal growth and promotes polyp formation in growth hormone-transgenic mice.
    Michaylira CZ; Ramocki NM; Simmons JG; Tanner CK; McNaughton KK; Woosley JT; Greenhalgh CJ; Lund PK
    Endocrinology; 2006 Apr; 147(4):1632-41. PubMed ID: 16410303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A designed cell-penetrating human SOCS2 protein suppresses GH-dependent cancer cell proliferation.
    Miyamoto A; Masuhiro Y; Seki T; Hanazawa S; Shiba H
    Biosci Biotechnol Biochem; 2019 Feb; 83(2):300-308. PubMed ID: 30343638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 17β-Estradiol positively modulates growth hormone signaling through the reduction of SOCS2 negative feedback in human osteoblasts.
    Bolamperti S; Mrak E; Moro G; Sirtori P; Fraschini G; Guidobono F; Rubinacci A; Villa I
    Bone; 2013 Jul; 55(1):84-92. PubMed ID: 23567159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GH/STAT5 signaling during the growth period in livers of mice overexpressing GH.
    Martinez CS; Piazza VG; Díaz ME; Boparai RK; Arum O; Ramírez MC; González L; Becú-Villalobos D; Bartke A; Turyn D; Miquet JG; Sotelo AI
    J Mol Endocrinol; 2015 Apr; 54(2):171-84. PubMed ID: 25691498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of growth hormone (GH) in liver regeneration.
    Pennisi PA; Kopchick JJ; Thorgeirsson S; LeRoith D; Yakar S
    Endocrinology; 2004 Oct; 145(10):4748-55. PubMed ID: 15242989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressor of cytokine signaling 2 (
    Dobie R; MacRae VE; Pass C; Milne EM; Ahmed SF; Farquharson C
    Dis Model Mech; 2018 Jan; 11(1):. PubMed ID: 29343614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GH receptor plays a major role in liver regeneration through the control of EGFR and ERK1/2 activation.
    Zerrad-Saadi A; Lambert-Blot M; Mitchell C; Bretes H; Collin de l'Hortet A; Baud V; Chereau F; Sotiropoulos A; Kopchick JJ; Liao L; Xu J; Gilgenkrantz H; Guidotti JE
    Endocrinology; 2011 Jul; 152(7):2731-41. PubMed ID: 21540290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of the GHRH/GH/IGF1 axis in a mouse model of Börjeson-Forssman-Lehman syndrome.
    McRae HM; Eccles S; Whitehead L; Alexander WS; Gécz J; Thomas T; Voss AK
    Development; 2020 Oct; 147(21):. PubMed ID: 32994169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.